Aurobindo Pharma shares gain over 4% as Q4 net profit climbs 39%

By: |
New Delhi | Updated: May 31, 2016 4:59:05 PM

Aurobindo Pharma shares advanced as much as 4.32 per cent on Tuesday after the company posted a jump of 39.39 per cent in its consolidated net profit figures at Rs 562.85 crore for the quarter ended March 31, 2016

aurobindo pharma sharesAurobindo Pharma shares advanced as much as 4.32 per cent on Tuesday after the company posted a jump of 39.39 per cent in its consolidated net profit figures at Rs 562.85 crore for the quarter ended March 31, 2016 (Reuters)

Aurobindo Pharma shares advanced as much as 4.32 per cent on Tuesday after the company posted a jump of 39.39 per cent in its consolidated net profit figures at Rs 562.85 crore for the quarter ended March 31, 2016 as compared to Rs 403.80 crore in the corresponding quarter in the FY15.

At 11.34 am, shares of Aurobindo Pharma were trading 3.81 per cent up at Rs 783.20. The scrip opened at Rs 772 and has touched a high and low of Rs 787.05 and Rs 761.10, respectively, in trade so far. Sensex was down 76.61 points, or 0.29 per cent, at 26,648.99.

Consolidated total income of the company increased by 18.89 per cent at Rs 3,767.34 crore for quarter under review as compared to Rs 3,168.81 crore for the same quarter ended previous year.

On Q4 results of Aurobindo Pharma, Sarabjit Kour Nangra, VP- research pharma, Angel Broking said, “For 4QFY2016, the company posted results below expectations on the net profit, while sales and operating profit margins were mostly in line with the expectations. We maintain our ‘Buy’ rating on the stock.”

The promoters holding in the pharma company stood at 53.79 per cent while institutions and non-institutions held 34.67 per cent and 11.54 per cent respectively.

On standalone basis, the pharma company registered a rise of 21.02 per cent in its net profit at Rs 407.85 crore for the quarter ended March 31, 2016 as compared to of Rs 337.01 crore for the same quarter in the previous year. Total income of the company has increased by 18.15 per cent at Rs 2,415.69 crore for quarter under review as compared to Rs 2,044.68 crore for the quarter ended March 31, 2015.

Later, the scrip closed 4.12 per cent up at Rs 785.55.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.